Ucb SA :UCB UPGRADES 2025 FINANCIAL GUIDANCE BASED ON STRONG PERFORMANCEBRIVIACT® IS EXPECTED TO FACE LOSS-OF-EXCLUSIVITY IN 20262025 REVENU EXPECTED TO EXCEED EUR 7.6 BILLION2025 ADJUSTED EBITDA MARGIN IS ANTICIPATED TO BE HIGHER THAN 31%EXPANDING USE OF BIMZELX® IN U.S. MAY AFFECT ITS NET PRICING